News & Updates

New drug applications approved by US FDA as of 01-15 January 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Adopting a low-microbial, protective (neutropenic) diet offers no clear benefit to patients following hematopoietic stem cell transplantation (HSCT) in a study described as the first to investigate the role of neutropenic diet post-HSCT.

Delivery of continuous, in situ–targeted, ultrahigh concentration of antibiotics (CITA) is a safe and effective therapy for patients with pocket infection who are neither suited nor willing to undergo extraction of implanted cardiovascular electronic device, reports a study.

Use of artificial intelligence (AI) to interpret radiographic images is possible if it can learn to read “noninterpretable images,” such as those of the abdomen and the axial skeleton, suggests a UK study.

Despite the increasing prevalence of childhood allergies, most parents are unprepared to manage them, a two-part study has shown.

Advances in bronchoscopic technology have been increasingly applied for diagnosing peripheral pulmonary lesions, but a recent study has found that such advances have not translated to improved diagnostic yield.